New Ebola Treatment in Gummy Form Prepares for Clinical Trials in Congo

Kinshasa, Monday, 6 July 2026.
NanoViricides is preparing Phase II trials in the DRC for NV-387, an innovative Ebola treatment delivered as room-temperature stable oral gummies, bypassing critical refrigeration and water infrastructure needs.